Literature DB >> 22547011

Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.

Dapeng Lin, Yiming Li, Huimian Xu, Junqing Chen, Binbin Wang, Caigang Liu, Ping Lu.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the outcome of the ratio between metastatic and examined lymph nodes (N ratio) in gastric cancer patients with <15 examined lymph nodes after curative resection.
METHODS: A retrospective study of 710 patients who underwent radical gastrectomy (R0) for gastric cancer from January 1980 to December 2000 was analyzed statistically to identify the N ratio. Patients with <15 examined lymph nodes (group 1, n=327) and those with ≥15 examined lymph nodes (group 2, n=383) were analyzed separately. N ratio categories were identified as follows: N ratio 0, 0%; N ratio 1, 1% to 9%; N ratio 2, 10% to 25%; and N ratio 3, >25%. All the enrolled categories were evaluated by the best cutoff approach.
RESULTS: The univariate analysis showed that age, tumor site, tumor size, surgery, T categories, number of metastatic nodes, and N ratio significantly affected prognosis in groups 1 and 2. By multivariate analysis, the N ratio (but not the TNM N category) classification was retained as an independent prognostic factor in groups 1 and 2 compared with the N category system. However, patients with N1 disease in group 1 obtained a better postoperative prognosis than those with N1 disease in group 2 according to the N stage classification (P=0.003). When the N ratio classification was applied, no significant differences were found for N ratios 0, 1, 2, or 3 between the 2 groups (P>0.05).
CONCLUSIONS: The metastatic lymph node ratio is an independent prognostic factor regardless of the examined number of lymph nodes. In predicting the prognosis of gastric cancer, the staging system based on the metastatic lymph node ratio is more reliable than the system based on the number of metastatic lymph nodes regardless of the examined number of lymph nodes. This can help improve the TNM staging classification of gastric cancer and reduce the International Union Against Cancer N categories of stage migration.

Entities:  

Mesh:

Year:  2013        PMID: 22547011     DOI: 10.1097/COC.0b013e318246b4e9

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  31 in total

1.  Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

Review 2.  Prognostic impact of nodal status and therapeutic implications.

Authors:  Katja Ott; Susanne Blank; Laura Ruspi; Margit Bauer; Leila Sisic; Thomas Schmidt
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-15

3.  Prognostic Value of Metastatic Lymph Node Ratio in Pancreatic Cancer.

Authors:  Can A Karaca; Ahmet Coker
Journal:  Indian J Surg Oncol       Date:  2018-10-26

4.  Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?

Authors:  Paolo Aurello; Niccolò Petrucciani; Giuseppe R Nigri; Marco La Torre; Paolo Magistri; Simone Tierno; Francesco D'Angelo; Giovanni Ramacciato
Journal:  J Gastrointest Surg       Date:  2014-05-20       Impact factor: 3.452

5.  A long non-coding RNA signature to improve prognosis prediction of gastric cancer.

Authors:  Xiaoqiang Zhu; Xianglong Tian; Chenyang Yu; Chaoqin Shen; Tingting Yan; Jie Hong; Zheng Wang; Jing-Yuan Fang; Haoyan Chen
Journal:  Mol Cancer       Date:  2016-09-20       Impact factor: 27.401

Review 6.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Impact of retrieved lymph node count on short-term complications in patients with gastric cancer.

Authors:  Feng Sun; Song Liu; Peng Song; Chen Zhang; Zhijian Liu; Wenxian Guan; Meng Wang
Journal:  World J Surg Oncol       Date:  2020-08-24       Impact factor: 2.754

8.  Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.

Authors:  Shumei Yan; Fan He; Rongzhen Luo; Huini Wu; Mayan Huang; Chunyu Huang; Yong Li; Zhiwei Zhou
Journal:  Tumour Biol       Date:  2015-11-26

9.  Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma.

Authors:  Eun Mee Oh; Yoo Seung Chung; Young Don Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

10.  The efficacy and toxicity of adjuvant S-1 schedule with 2-week administration followed by 1-week rest in gastric cancer patients.

Authors:  Yu-Yin Liu; Yueh-Wei Liu; Yen-Yang Chen; Shih-Ho Wang; Seng-Kee Chuah; Gong-Kai Huang; Yen-Hao Chen
Journal:  J Gastrointest Oncol       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.